Related Experiment Video
Updated: Feb 8, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Restoration of microRNA-130b expression suppresses osteosarcoma cell malignant behavior in vitro
Yi Wu1,2, Wei Sun1, Ying Kong1
1Department of Orthopedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China.
Abstract:
The alteration of microRNA (miR)-130b expression has been associated with promoting or suppressing numerous types of human cancer. A previous study evaluated the expression level of miR-130b in osteosarcoma tissues, and subsequently investigated the effects of miR-130b on the regulation of osteosarcoma cells malignant behavior in vitro. The study revealed that miR-130b expression levels were significantly reduced in osteosarcoma tissues and cell lines, compared with in adjacent tissues or normal cell lines. The expression of miR-130b inhibited the proliferation of osteosarcoma U-2OS and Saos-2 cells and impaired their ability to migrate, invade and form colonies. Furthermore, analysis using TargetScan and a dual-luciferase reporter assay demonstrated that miR-130b directly interacted with the 3'-untranslated region of transforming growth factor α (TGFA) and suppressed TGFA expression. TGFA and miR-130b were also inversely expressed in osteosarcoma tissues. In addition, expression of TGFA was able to alter miR-130-regulated osteosarcoma cell proliferation, migration and invasion. Thus, the present study demonstrated that miR-130b was downregulated in osteosarcoma tissues and cell lines, whereas the expression of miR-130b suppressed osteosarcoma cell malignant behavior. At the gene level, miR-130 directly targets and inhibits TGFA expression, in addition to phosphorylated protein kinase B and epidermal growth factor receptor expression levels. Further study is required to evaluate miR-130b antitumor activity in osteosarcoma.
Insights
MicroRNA (miR)-130b is downregulated in osteosarcoma, suppressing cancer cell growth and invasion. This study shows miR-130b targets transforming growth factor alpha (TGFA), indicating its potential as an osteosarcoma therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNA (miR)-130b dysregulation is implicated in various human cancers.
- Osteosarcoma is a primary bone cancer with significant morbidity.
- Understanding miR-130b's role in osteosarcoma is crucial for therapeutic development.
Purpose of the Study:
- To evaluate miR-130b expression levels in osteosarcoma tissues and cell lines.
- To investigate the functional impact of miR-130b on osteosarcoma cell malignancy.
- To identify the direct molecular targets of miR-130b in osteosarcoma.
Main Methods:
- Quantitative analysis of miR-130b expression in patient tissues and cell lines.
- In vitro assays to assess cell proliferation, migration, invasion, and colony formation.
- Bioinformatic analysis (TargetScan) and dual-luciferase reporter assays to confirm direct gene targets.
Main Results:
- miR-130b expression was significantly reduced in osteosarcoma tissues and cell lines compared to controls.
- Restored miR-130b expression inhibited osteosarcoma cell proliferation, migration, invasion, and colony formation.
- miR-130b directly targets and suppresses the expression of transforming growth factor alpha (TGFA).
Conclusions:
- miR-130b acts as a tumor suppressor in osteosarcoma by inhibiting malignant behaviors.
- The inverse correlation between miR-130b and TGFA suggests a critical regulatory axis.
- miR-130b warrants further investigation as a potential therapeutic agent for osteosarcoma.
Related Concept Videos
MicroRNAs
MicroRNAs
Restorative Care
Cell Specific Gene Expression
Cell Specific Gene Expression
What is Behavior?

